Literature DB >> 16926587

Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation.

Herman Blomeier1, Xiaomin Zhang, Christopher Rives, Marcela Brissova, Elizabeth Hughes, Marshall Baker, Alvin C Powers, Dixon B Kaufman, Lonnie D Shea, William L Lowe.   

Abstract

BACKGROUND: Problems associated with the hepatic transplantation of islets may preclude the broad application of islet transplantation. Thus, we sought to develop an approach to the extrahepatic transplantation of islets using a synthetic biodegradable polymer scaffold.
METHODS: Microporous polymer scaffolds that allow vascular ingrowth and nutrient diffusion from host tissues were fabricated from copolymers of lactide and glycolide. Murine islets were transplanted without or with a scaffold onto intraperitoneal fat of syngeneic diabetic recipients. Bioluminescence imaging using a cooled charge-coupled device camera, immunohistochemistry, and glycemia were used to assess islet engraftment and function posttransplant.
RESULTS: By bioluminescence imaging, islets transplanted on a polymer scaffold remain localized to the transplant site and survive for an extended period of time. Islets transplanted on scaffolds retained the architecture of native islets and developed a functional islet vasculature. Transplantation of marginal masses of islets on the polymer scaffold demonstrated improved islet function compared to transplantation without a scaffold as assessed by the effectiveness of diabetes reversal, including mean time required to achieve euglycemia, weight gain, and glucose levels during an intraperitoneal glucose tolerance test.
CONCLUSION: These findings indicate that a synthetic polymer scaffold can serve as a platform for islet transplantation and improves the function of extrahepatically transplanted islets compared to islets transplanted without a scaffold. The scaffold may also be useful to deliver bioactive molecules to modify the microenvironment surrounding the transplanted islets and, thus, enhance islet survival and function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926587      PMCID: PMC2648394          DOI: 10.1097/01.tp.0000231708.19937.21

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  40 in total

1.  DNA delivery from polymer matrices for tissue engineering.

Authors:  L D Shea; E Smiley; J Bonadio; D J Mooney
Journal:  Nat Biotechnol       Date:  1999-06       Impact factor: 54.908

2.  Design and fabrication of biodegradable polymer devices to engineer tubular tissues.

Authors:  D J Mooney; G Organ; J P Vacanti; R Langer
Journal:  Cell Transplant       Date:  1994 Mar-Apr       Impact factor: 4.064

3.  Specific inhibition of macrophage-derived proinflammatory cytokine synthesis with a tetravalent guanylhydrazone CNI-1493 accelerates early islet graft function posttransplant.

Authors:  S H Hyon; K J Tracey; D B Kaufman
Journal:  Transplant Proc       Date:  1998-03       Impact factor: 1.066

Review 4.  Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.

Authors:  Neal R Barshes; Samuel Wyllie; John A Goss
Journal:  J Leukoc Biol       Date:  2005-02-22       Impact factor: 4.962

5.  Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds.

Authors:  William L Murphy; Robert G Dennis; Joel L Kileny; David J Mooney
Journal:  Tissue Eng       Date:  2002-02

6.  Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts.

Authors:  Daniel Nyqvist; Martin Köhler; Helene Wahlstedt; Per-Olof Berggren
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

7.  Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats.

Authors:  F Dombrowski; P Bannasch; U Pfeifer
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

8.  Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation.

Authors:  R Bottino; L A Fernandez; C Ricordi; R Lehmann; M F Tsan; R Oliver; L Inverardi
Journal:  Diabetes       Date:  1998-03       Impact factor: 9.461

9.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

10.  Neurotrophin releasing single and multiple lumen nerve conduits.

Authors:  Yang Yang; Laura De Laporte; Christopher B Rives; Jae-Hyung Jang; Wei-Chun Lin; Kenneth R Shull; Lonnie D Shea
Journal:  J Control Release       Date:  2005-06-02       Impact factor: 9.776

View more
  52 in total

Review 1.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models.

Authors:  Romie F Gibly; Xiaomin Zhang; Melanie L Graham; Bernhard J Hering; Dixon B Kaufman; William L Lowe; Lonnie D Shea
Journal:  Biomaterials       Date:  2011-09-28       Impact factor: 12.479

3.  Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function.

Authors:  Malek El Muayed; Liana K Billings; Meera R Raja; Xiaomin Zhang; Paul J Park; Marsha V Newman; Dixon B Kaufman; Thomas V O'Halloran; William L Lowe
Journal:  J Endocrinol       Date:  2010-05-27       Impact factor: 4.286

Review 4.  Advancing islet transplantation: from engraftment to the immune response.

Authors:  R F Gibly; J G Graham; X Luo; W L Lowe; B J Hering; L D Shea
Journal:  Diabetologia       Date:  2011-08-10       Impact factor: 10.122

5.  Multiple channel bridges for spinal cord injury: cellular characterization of host response.

Authors:  Yang Yang; Laura De Laporte; Marina L Zelivyanskaya; Kevin J Whittlesey; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

6.  Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia.

Authors:  Woon Teck Yap; David M Salvay; Michael A Silliman; Xiaomin Zhang; Zachary G Bannon; Dixon B Kaufman; William L Lowe; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-06-27       Impact factor: 3.845

7.  PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.

Authors:  John G Graham; Xiaomin Zhang; Ashley Goodman; Kathryn Pothoven; Josetta Houlihan; Shusen Wang; R Michael Gower; Xunrong Luo; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2013-04-03       Impact factor: 3.845

Review 8.  Bioprinting an Artificial Pancreas for Type 1 Diabetes.

Authors:  Juewan Kim; Kyungwon Kang; Christopher J Drogemuller; Gordon G Wallace; P Toby Coates
Journal:  Curr Diab Rep       Date:  2019-07-04       Impact factor: 4.810

9.  Macroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation.

Authors:  Eileen Pedraza; Ann-Christina Brady; Christopher A Fraker; R Damaris Molano; Steven Sukert; Dora M Berman; Norma S Kenyon; Antonello Pileggi; Camillo Ricordi; Cherie L Stabler
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

10.  Localized immune tolerance from FasL-functionalized PLG scaffolds.

Authors:  Michael Skoumal; Kyle B Woodward; Hong Zhao; Feng Wang; Esma S Yolcu; Ryan M Pearson; Kevin R Hughes; Andrés J García; Lonnie D Shea; Haval Shirwan
Journal:  Biomaterials       Date:  2018-11-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.